CHITRA VENKATRAMAN M.D. NPI 1558354860

NPI Information

  • NPI: 1558354860
  • Provider Name: CHITRA VENKATRAMAN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • CLIA Number: 21D0973051
  • Address: 7300 HANOVER DRIVE
    SUITE 301
    GREENBELT, MD
    ZIP 20770
  • Phone: (301) 345-1800

Map and Directions

Get Directions

NPI Details

Chitra Venkatraman, M.D. is a hematology and oncology internal medicine in Greenbelt, MD with 40 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Chitra Venkatraman, M.D. NPI is 1558354860. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

7300 HANOVER DRIVE
SUITE 301
GREENBELT, MD
ZIP 20770
Phone: (301) 345-1800
Fax: (301) 345-3854

The NPI 1558354860 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 21D0973051 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg (HCPCS:J2916)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Ringers lactate infusion, up to 1000 cc (HCPCS:J7120)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Biopsy of bone marrow (HCPCS:38221)
  • Aspiration of bone marrow sample for diagnosis (HCPCS:38220)

The enumeration date for this NPI number is 8/23/2005 and was last updated on 3/19/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialistD41715MARYLANDNo
2207RH0003XInternal MedicineHematology & OncologyD41715MARYLANDYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1522208885OTHERTAX ID
2697251900MEDICAIDMARYLAND
3D41715OTHERMARYLANDLICENSE
41558354860OTHERNPI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.